Skip to content

Cryospray to Reduce Pain During Venous Cannulation

Cryospray to Reduce Pain During Venous Cannulation - Randomized Placebo-controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04865783
Enrollment
130
Registered
2021-04-29
Start date
2021-05-25
Completion date
2023-07-18
Last updated
2024-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheterization, Anesthetics, Intravenous, Elective Surgical Procedures

Keywords

cryospray

Brief summary

This trial aims to evaluate if cryospray can reduce pain during intravenous cannulation in elective surgery compared to a placebo spray.

Detailed description

Venous cannulation is a common practice in the health care system. Before any procedure, intravenous access is always placed before induction of any anaesthesia. For many patients placement of a venous catheter is associated with pain and discomfort. Any quick and easy reduction in pain during the procedure is important for patients. Cryospray has been described as an easy-to-use supplement of analgesia to alleviate pain during intravenous access. Cryospray has been shown to reduce pain in venous cannulation in the emergency setting but not in the elective setting. A search in the literature reveals 2 recent metanalyses reporting 8 included trials and 11 included trials, respectively. Both metanalyses call for further research in relation to patients' satisfaction. By randomizing patients to either cryospray or placebo before venous cannulation, we hypothesize that cryospray reduces pain during venous cannulation compared to placebo.

Interventions

PROCEDURESaline spray

The saline spray will be applied twice for 1-2 seconds.

PROCEDURECryospray

The cryospray will be applied twice for 1-2 seconds.

Sponsors

University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

Before elective surgery, all patients will have an intravenous line placed before induction of anaesthesia. Patients will be blinded to whether cryospray or placebo is used. Two anaesthesia trained persons (nurse/doctors) will perform the procedure. One person will randomize and apply the randomized spray and the other person will be blinded to the randomized treatment. The anesthesiologist performing the puncture but blinded for randomization will fill out a questionnaire

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older and able to give consent

Exclusion criteria

* Unable to give consent * Infection * coloring or bruises at the puncture site (use of corticosteroid etc). * No vein signs visible after application of vein stasis. * Allergy to coolant spray. * Contraindication for vein stasis or vein cannulation (ex Raynauds disease etc). * Has participated earlier in the trial.

Design outcomes

Primary

MeasureTime frameDescription
Patients reported pain from the puncture siteimmediately after completion of vein canulationAfter vein puncture is completed patients is asked on a scale from 0-10 to indicate pain during vein canulation (zero no pain, 10 worst possible pain)

Secondary

MeasureTime frameDescription
Difficulty in placement of intravenous lineimmediately after completion of vein canulationAfter vein puncture is completed the operator is asked to the difficulty in placement of the venous line (0-10, zero very easy and ten very difficult).
Number of successful placements of venous line at first attemptimmediately after completion of vein canulationAfter vein puncture is completed it is indicated wether or not it was successful in first attempt.

Other

MeasureTime frameDescription
Discomfort from puncture site at discharge from recoveryup to 24 hours after discharge from recovery roomAfter discharge from the recovery room patients is asked for any discomfort at the puncture site. If yes: pain, numbness, burning or cold feeling. All positive values rated on the numeric rating scale (0-10).

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026